- Home
- GMM vs YI Comparison
GMM vs YI Comparison
Compare GMM & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- YI
- Stock Information
- Founded
- GMM 2017
- YI 2010
- Country
- GMM China
- YI China
- Employees
- GMM N/A
- YI N/A
- Industry
- GMM
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- GMM
- YI Consumer Staples
- Exchange
- GMM Nasdaq
- YI Nasdaq
- Market Cap
- GMM 61.9M
- YI 60.7M
- IPO Year
- GMM 2023
- YI N/A
- Fundamental
- Price
- GMM N/A
- YI N/A
- Analyst Decision
- GMM
- YI
- Analyst Count
- GMM 0
- YI 0
- Target Price
- GMM N/A
- YI N/A
- AVG Volume (30 Days)
- GMM 699.8K
- YI 28.0K
- Earning Date
- GMM 08-18-2025
- YI 11-26-2025
- Dividend Yield
- GMM N/A
- YI N/A
- EPS Growth
- GMM N/A
- YI N/A
- EPS
- GMM 1.79
- YI N/A
- Revenue
- GMM $48,171,048.00
- YI $1,979,883,442.00
- Revenue This Year
- GMM N/A
- YI N/A
- Revenue Next Year
- GMM N/A
- YI N/A
- P/E Ratio
- GMM $1.12
- YI N/A
- Revenue Growth
- GMM 41.74
- YI N/A
- 52 Week Low
- GMM $1.69
- YI $4.15
- 52 Week High
- GMM $10.50
- YI $11.80
- Technical
- Relative Strength Index (RSI)
- GMM 45.28
- YI N/A
- Support Level
- GMM $1.90
- YI N/A
- Resistance Level
- GMM $2.04
- YI N/A
- Average True Range (ATR)
- GMM 0.13
- YI 0.00
- MACD
- GMM 0.01
- YI 0.00
- Stochastic Oscillator
- GMM 42.89
- YI 0.00
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.